Edition:
United Kingdom

Ligand Pharmaceuticals Inc (LGND.OQ)

LGND.OQ on NASDAQ Stock Exchange Global Market

265.91USD
18 Sep 2018
Change (% chg)

$12.24 (+4.83%)
Prev Close
$253.67
Open
$268.00
Day's High
$273.15
Day's Low
$263.58
Volume
152,984
Avg. Vol
106,541
52-wk High
$273.15
52-wk Low
$126.77

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

John Kozarich

68 2017 Non-Executive Independent Chairman of the Board

Matthew Foehr

45 2015 President, Chief Operating Officer

John Higgins

48 2015 Chief Executive Officer, Director

Matthew Korenberg

43 2018 Chief Financial Officer, Executive Vice President - Finance

Charles Berkman

49 2018 Senior Vice President, General Counsel, Secretary